Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis

Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis

Background and objective: Best-value biological medicines may generate competition in the off-patent biologicals market, resulting in having more resources available to provide patients with access to necessary medicines while maintaining high-quality care. Belgium is a country known to have low bio...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Yannick Vandenplas, Steven Simoens, Philippe Van Wilder, Arnold G. Vulto, Isabelle Huys
Materialtyp: Artikel
Språk:English
Publicerad: Frontiers Media S.A. 2021-04-01
Serie:Frontiers in Pharmacology
Ämnen:
biological
medicine
competition
sustainability
market access
affordability
Länkar:https://www.frontiersin.org/articles/10.3389/fphar.2021.644187/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.644187/full

Liknande verk